Evidence supporting the use of: 1,3,7-Trimethylpurine-2,6-dione
For the health condition: Narcolepsy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

1,3,7-Trimethylpurine-2,6-dione is the chemical name for caffeine. Caffeine has a well-documented central nervous system stimulant effect. Its primary mechanism of action is antagonism of adenosine receptors, leading to increased alertness and wakefulness. For narcolepsy, which is characterized by excessive daytime sleepiness, caffeine has traditionally been utilized as an alerting agent, both in general populations and among narcoleptics. There is moderate scientific evidence supporting its use: clinical guidelines acknowledge caffeine as an option for symptom management, particularly where prescription stimulants (such as modafinil or amphetamines) are unavailable or contraindicated.

Randomized controlled trials specifically evaluating caffeine in narcolepsy are limited and often small. However, caffeine’s efficacy in reducing subjective sleepiness and improving sustained attention in narcoleptic patients has been demonstrated in some studies, though its effect size is generally less than that of prescription stimulants. Furthermore, caffeine is sometimes used as an adjunct for residual daytime sleepiness in patients treated with other medications.

In summary, while caffeine is not the first-line pharmacological treatment for narcolepsy, there is moderate scientific validation for its use as a symptomatic aid. Its widespread availability, low cost, and established safety profile make it a reasonable alternative or supplement for some patients, but it is generally considered less effective than approved stimulant medications.

More about 1,3,7-Trimethylpurine-2,6-dione
More about Narcolepsy

Products containing 1,3,7-Trimethylpurine-2,6-dione

We currently have no products on Vitabase that contain this ingredient.